Search - tctmd.com

Displaying 61 - 80 of 432

Sort: Relevancy | Date

News Daily News

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

L.A. McKeown

July 02, 2024

News Opinion CV Team Dispatch

July 2024 Dispatch for the CV Team

L.A. McKeown

July 01, 2024

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

News Daily News

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Todd Neale

June 26, 2024

News Daily News

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

L.A. McKeown

June 05, 2024

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

News Conference News SCAI 2024

AI Picks Up on Info Operators Miss on Angiograms: AI-ENCODE

L.A. McKeown

May 03, 2024

News Conference News SCAI 2024

CALORI: More Support for Eschewing Fasting Protocols Preprocedure

L.A. McKeown

May 02, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Conference News ACC 2024

Need a Statin for Primary Prevention? There’s an App for That

Michael O'Riordan

April 10, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

$Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)$

Presentation ACC 2024

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Presenter: Rasha K. Al-Lamee

April 08, 2024

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

L.A. McKeown

April 01, 2024

News Conference News CRT 2024

SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI

L.A. McKeown

March 15, 2024

News Daily News

Physicians (Mostly) Negative on Private Equity in Healthcare

Michael O'Riordan

March 13, 2024

News Daily News

One in Three Overweight MI Patients May Benefit From Semaglutide

Todd Neale

February 26, 2024

News Daily News

Alcohol’s Impact on IHD Mortality Hinges on Socioeconomic Status

Caitlin E. Cox

February 07, 2024

News Opinion CV Team Dispatch

February 2024 Dispatch for the CV Team

L.A. McKeown

February 01, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2024

Shelley Wood

February 01, 2024

News Features

Going Solo: Can TAVI Be Performed Without a Surgical Safety Net?

Michael O'Riordan

January 22, 2024

Advertisement

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

July 2024 Dispatch for the CV Team

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Semaglutide Has Similar Benefits in Women and Men With HFpEF

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

June 2024 Dispatch for the CV Team

AI Picks Up on Info Operators Miss on Angiograms: AI-ENCODE

CALORI: More Support for Eschewing Fasting Protocols Preprocedure

May 2024 Dispatch for the CV Team

Need a Statin for Primary Prevention? There’s an App for That

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

April 2024 Dispatch for the CV Team

SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI

Physicians (Mostly) Negative on Private Equity in Healthcare

One in Three Overweight MI Patients May Benefit From Semaglutide

Alcohol’s Impact on IHD Mortality Hinges on Socioeconomic Status

February 2024 Dispatch for the CV Team

TCTMD’s Top 10 Most Popular Stories for January 2024

Going Solo: Can TAVI Be Performed Without a Surgical Safety Net?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content